Dun & Bradstreet Launches D&B Healthcare Insights, Expanding Market Reach in Healthcare Sector
ByAinvest
Friday, Aug 1, 2025 8:58 am ET1min read
DNB--
D&B Healthcare Insights integrates with D&B Hoovers' extensive database of over 320 million companies and 485 million contacts, combining it with healthcare-specific data covering more than 260,000 healthcare organizations. Users can access detailed information including facility profiles, operating room size, bed counts, procedure volumes, staffing numbers, and total visits. This healthcare dataset is the first in a series of new data offerings planned by Dun & Bradstreet for 2025 [1].
The platform's ability to provide specialized healthcare data sets it apart from generic business databases, allowing for more targeted sales and marketing strategies. Dun & Bradstreet's move into the healthcare sector addresses a common enterprise software challenge - how to extract more revenue from existing customers by offering high-value add-ons rather than relying solely on new customer acquisition [2].
The product architecture follows the proven SaaS playbook of modular design, offering the core D&B Hoovers platform with specialized data overlays that can be monetized as premium add-ons. This creates upsell opportunities within D&B's existing customer base while potentially attracting new clients specifically interested in healthcare intelligence [1].
Healthcare is just the first in a series of new, high-impact datasets Dun & Bradstreet plans to introduce this year, continuing to expand its data capabilities to serve the evolving needs of its clients and the industries they lead [2]. Dun & Bradstreet's new healthcare data product expands addressable market and strengthens its competitive position in the high-value healthcare vertical [1].
References:
[1] https://www.stocktitan.net/news/DNB/dun-bradstreet-unveils-d-b-healthcare-insights-to-help-sales-and-vkdsqe5al8yj.html
[2] https://www.prnewswire.com/news-releases/dun--bradstreet-unveils-db-healthcare-insights-to-help-sales-and-marketing-teams-across-industries-unlock-opportunities-in-the-healthcare-ecosystem-302517935.html
Dun & Bradstreet has launched D&B Healthcare Insights, a new dataset designed to enhance sales and marketing intelligence for companies targeting the healthcare sector. The platform integrates with D&B Hoovers and provides detailed information on healthcare organizations and healthcare providers, covering over 260,000 entities. This expansion into the healthcare sector is part of Dun & Bradstreet's plan to introduce new data offerings this year, aiming to create vertical-specific differentiation and command premium pricing.
Dun & Bradstreet (NYSE: DNB) has launched D&B Healthcare Insights, a comprehensive dataset designed to enhance sales and marketing intelligence for companies targeting the healthcare sector. The new solution, available as an add-on to D&B Hoovers, provides detailed information about healthcare organizations (HCOs) and healthcare providers (HCPs). This expansion into the healthcare sector is part of Dun & Bradstreet's plan to introduce new data offerings this year, aiming to create vertical-specific differentiation and command premium pricing.D&B Healthcare Insights integrates with D&B Hoovers' extensive database of over 320 million companies and 485 million contacts, combining it with healthcare-specific data covering more than 260,000 healthcare organizations. Users can access detailed information including facility profiles, operating room size, bed counts, procedure volumes, staffing numbers, and total visits. This healthcare dataset is the first in a series of new data offerings planned by Dun & Bradstreet for 2025 [1].
The platform's ability to provide specialized healthcare data sets it apart from generic business databases, allowing for more targeted sales and marketing strategies. Dun & Bradstreet's move into the healthcare sector addresses a common enterprise software challenge - how to extract more revenue from existing customers by offering high-value add-ons rather than relying solely on new customer acquisition [2].
The product architecture follows the proven SaaS playbook of modular design, offering the core D&B Hoovers platform with specialized data overlays that can be monetized as premium add-ons. This creates upsell opportunities within D&B's existing customer base while potentially attracting new clients specifically interested in healthcare intelligence [1].
Healthcare is just the first in a series of new, high-impact datasets Dun & Bradstreet plans to introduce this year, continuing to expand its data capabilities to serve the evolving needs of its clients and the industries they lead [2]. Dun & Bradstreet's new healthcare data product expands addressable market and strengthens its competitive position in the high-value healthcare vertical [1].
References:
[1] https://www.stocktitan.net/news/DNB/dun-bradstreet-unveils-d-b-healthcare-insights-to-help-sales-and-vkdsqe5al8yj.html
[2] https://www.prnewswire.com/news-releases/dun--bradstreet-unveils-db-healthcare-insights-to-help-sales-and-marketing-teams-across-industries-unlock-opportunities-in-the-healthcare-ecosystem-302517935.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet